GPODS, INC. financials

GPOD CIK 0001748232

Source: EDGAR filings · Built 2026-10-15T00:00:50Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow — — — -25.55K -1.40K -6.14K
Net Debt 187.91K 171.73K 159.83K 116.09K 103.03K 102.87K
Return on Equity (ROE) 56.12% -6.73% 15.81% 34.21% 10.19% 12.54%
Return on Assets (ROA) -361.75% 23.81% -232.17% -464.97% -26.65% -31.60%
Debt-to-Equity -0.24× -0.43× -0.10× -0.09× -0.12× -0.13×
Effective Tax Rate — — -0.32% -0.18% -0.90% -0.81%
Cash Conversion Ratio 0.76× -7.20× 0.47× 0.04× 0.01× 0.01×
Accruals Ratio -0.87× 1.95× -1.22× -4.44× -0.26× -0.31×
CapEx Coverage — — — -3.72× -4.00× -0.12×
Free Cash Flow Per Share — — — $-0.00 $-0.00 $-0.00

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cost of Revenue — 0 — — — —
Operating Expenses 487.85K 222.93K 249.14K 453.14K 88.92K 98.34K
Operating Income (Loss) -487.85K -222.93K -249.14K — — —
Income Tax Expense (Benefit) — — 800 800 800 800
Net Income (Loss) Attributable to Parent -487.85K 27.07K -249.14K -453.94K -89.72K -99.14K
Earnings Per Share, Basic $-0.02 $0.00 $-0.02 $-0.03 $-0.01 $-0.01
Weighted Average Number of Shares Outstanding, Basic 22.90M 16.45M 16.27M 16.23M 16.20M 16.64M
Earnings Per Share, Diluted $-0.02 $0.00 $-0.02 $-0.03 $-0.01 $-0.01
Weighted Average Number of Shares Outstanding, Diluted 22.90M 16.45M 16.27M 16.23M 16.20M 16.64M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 21.61K 405 1.71K 7.43K 1.66K 1.81K
Assets, Current 26.26K 5.08K 1.71K 7.43K 2.11K 7.27K
Assets 134.86K 113.68K 107.31K 97.63K 336.61K 313.68K
Liabilities 1.00M 516.03K 1.68M 1.42M 1.22M 1.10M
Stockholders' Equity Attributable to Parent -869.25K -402.35K -1.58M -1.33M -880.19K -790.47K
Common Stock, Shares, Outstanding 22.98M 22.77M 16.27M 16.27M 16.20M 16.20M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -370.53K -194.80K -118.09K -20.14K -1.12K -671
Payments to Acquire Property, Plant, and Equipment — — — 5.41K 279 5.47K
Net Cash Provided by (Used in) Investing Activities — — — -5.41K -279 -5.47K
Net Cash Provided by (Used in) Financing Activities 391.73K 193.50K 112.37K 31.32K 1.24K 7.96K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GPOD CIK 0001748232), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AIDX

20/20 BIOLABS, INC.

GABC

German American Bancorp, Inc.

PHAR

Pharming Group N.V.